These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 10202046

  • 1. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX, Markees TG, Hancock WW, Li Y, Greiner DL, Li XC, Mordes JP, Sayegh MH, Rossini AA, Strom TB.
    J Immunol; 1999 Apr 15; 162(8):4983-90. PubMed ID: 10202046
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL.
    J Immunol; 2000 Jan 01; 164(1):512-21. PubMed ID: 10605049
    [Abstract] [Full Text] [Related]

  • 4. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.
    Saito K, Sakurai J, Ohata J, Kohsaka T, Hashimoto H, Okumura K, Abe R, Azuma M.
    J Immunol; 1998 May 01; 160(9):4225-31. PubMed ID: 9574523
    [Abstract] [Full Text] [Related]

  • 5. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Sharpe AH, Vallera DA.
    J Immunol; 1999 Jun 01; 162(11):6368-77. PubMed ID: 10352249
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
    Markees TG, Phillips NE, Gordon EJ, Noelle RJ, Shultz LD, Mordes JP, Greiner DL, Rossini AA.
    J Clin Invest; 1998 Jun 01; 101(11):2446-55. PubMed ID: 9616216
    [Abstract] [Full Text] [Related]

  • 9. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
    Gao D, Li J, Orosz CG, Bumgardner GL.
    Hepatology; 2000 Nov 01; 32(5):1018-28. PubMed ID: 11050052
    [Abstract] [Full Text] [Related]

  • 10. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J, Bingaman AW, Durham MM, Pearson TC, Larsen CP.
    Transpl Immunol; 2001 Oct 01; 9(1):13-7. PubMed ID: 11680567
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo.
    Niimi M, Pearson TC, Larsen CP, Alexander DZ, Hollenbaugh D, Aruffo A, Linsley PS, Thomas E, Campbell K, Fanslow WC, Geha RS, Morris PJ, Wood KJ.
    J Immunol; 1998 Nov 15; 161(10):5331-7. PubMed ID: 9820506
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
    Mandelbrot DA, Furukawa Y, McAdam AJ, Alexander SI, Libby P, Mitchell RN, Sharpe AH.
    J Immunol; 1999 Oct 01; 163(7):3753-7. PubMed ID: 10490971
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Blockade of CD40-CD40 ligand pathway induces tolerance in murine contact hypersensitivity.
    Tang A, Judge TA, Turka LA.
    Eur J Immunol; 1997 Dec 01; 27(12):3143-50. PubMed ID: 9464799
    [Abstract] [Full Text] [Related]

  • 17. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P, Szot GL, Guo Z, Kim O, He G, Wang J, Grusby MJ, Newell KA, Thistlethwaite JR, Bluestone JA, Alegre ML.
    J Immunol; 2000 Nov 15; 165(10):5580-7. PubMed ID: 11067913
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX, Fan LY, Wang Q.
    Eur Surg Res; 2011 Nov 15; 46(3):109-17. PubMed ID: 21242693
    [Abstract] [Full Text] [Related]

  • 20. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.
    Fan K, Wang H, Wei H, Zhou Q, Kou G, Hou S, Qian W, Dai J, Li B, Zhang Y, Zhu T, Guo Y.
    Transplantation; 2007 Sep 27; 84(6):746-54. PubMed ID: 17893608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.